For weight management, you may be suitable for semaglutide, tirzepatide or other GLP-1-based treatment if you have a BMI of 30 kg/m or higher, or a BMI of 27 kg/m with a weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes
Gut-Skin Axis Research Gut-skin axis models which examine the relationship between gut inflammation and dermal outcomes are a KPV-dependent use case
How It Works Shake & Spray: Gently shake the bottle, insert the nozzle, and dispense 1-2 sprays per nostril
Visible weight loss often begins around 3 to 6 weeks, while more steady and sustainable fat loss usually develops by 8 to 12 weeks
These medications are provided through our network of FDA-registered and inspected pharmacies, ensuring quality and adherence to regulatory standards